OVEREXPRESSION OF ARGINASE AND PROK-2 MAKES NEUTROPHILS OF MULTIPLE MYELOMA DYSFUNCTIONAL AND IMMUNOSUPPRESSIVE

EHA Library, Alessandra Romano, 103188

GENOMIC AND DRUG RESPONSE PROFILING OF FATAL TCF3-HLF-POSITIVE PEDIATRIC ACUTE LYMPHOBLASTICLEUKEMIA IDENTIFIES RECURRENT MUTATION PATTERNS AND NOVEL THERAPEUTIC OPTIONS

EHA Library, Jean-Pierre Bourquin, 103182

PATIENTS WITH HEAVILY PRETREATED DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) WHO RESPOND TO ORAL SELINEXOR THERAPY SHOW PROLONGED SURVIVAL: UDPATED PHASE 1 RESULTS

EHA Library, John Kuruvilla, 103169

MANAGEMENT AND OUTCOME OF PRIMARY CNS LYMPHOMA AT FIRST RELAPSE/PROGRESSION: ANALYSIS OF 256 PATIENTS FROM THE FRENCH LOC NETWORK

EHA Library, Sophie Langner-Lemercier, 103054

A COMPARISON OF DAUNORUBICIN/ARA-C VERSUS DAUNORUBICIN/CLOFARABINE AS INDUCTION TREATMENT IN OLDER PATIENTS WITH AML AND HIGH RISK MDS: LONG TERM RESULTS OF THE UK NCRI AML16 TRIAL IN 806 PATIENTS.

EHA Library, Nigel Russell, 103226

DEREGULATION OF SNO-RNAS IN THE GENOMICALLY IMPRINTED PRADER-WILLI LOCUS IN ERG-RELATED PEDIATRIC B CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Elena Vendramini, 103228

DISSECTING THE CONTRIBUTION OF UNREGULATED MACROPHAGE IRON RECYCLING AND DIETARY IRON UPTAKE IN GENERATING SYSTEMIC IRON OVERLOAD

EHA Library, Sandro Altamura, 103118

IMMUNOSUPPRESSION BY MESENCHYMAL STROMAL CELLS DERIVED FROM HUMAN INDUCED PLURIPOTENT STEM CELLS : EVALUATION IN AN AGVHD MODEL

EHA Library, Clémence Roux, 103167

SPIRIT 2: AN NCRI RANDOMISED STUDY COMPARING DASATINIB WITH IMATINIB IN PATIENTS WITH NEWLY-DIAGNOSED CHRONIC MYELOID LEUKAEMIA ? 2 YEAR FOLLOW UP

EHA Library, Stephen O'Brien, 103232

LUSPATERCEPT INCREASES HEMOGLOBIN AND REDUCES TRANSFUSION BURDEN IN PATIENTS WITH LOW OR INTERMEDIATE-1 RISK MYELODYSPLASTIC SYNDROMES (MDS): PRELIMINARY RESULTS FROM THE PHASE 2 PACE-MDS STUDY

EHA Library, Uwe Platzbecker, 103098

CLINICAL CHARACTERSTICS AND RISK FACTORS OF INTRACRANIAL HAEMORRHAGE IN PATIENTS FOLLOWING ALLOGENEIC HAEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Xiaohui Zhang, 103100

MIR-153-3P, A NEW BIO-TARGET, IS INVOLVED IN THE PATHOGENESIS OF ACUTE GRAFT-VERSUS-HOST DISEASE THROUGH THE REGULATION OF INDOLEAMINE-2,3-DIOXYGENASE

EHA Library, Xiaosu Zhao, 103139

FUNCTIONAL CHARACTERIZATION OF NOVEL ABCB6 MUTATIONS AND THEIR CLINICAL IMPLICATIONS IN FAMILIAL PSEUDOHYPERKALEMIA.

EHA Library, Immacolata Andolfo, 103150

A COMPARISON OF LIMITED CONSOLIDATION CHEMOTHERAPY THERAPY OR NOT, AND DEMETHYLATION MAINTENANCE OR NOT IN OLDER PATIENTS WITH AML AND HIGH RISK MDS: LONG TERM RESULTS OF THE UK NCRI AML16 TRIAL.

EHA Library, Alan Burnett, 103225

LONG-TERM OUTCOME OF ALTERNATING NILOTINIB 400 MG TWICE DAILY AND IMATINIB 400 MG ONCE DAILY AS FIRST-LINE TREATMENT OF CHRONIC MYELOID LEUKEMIA: A PHASE 2 STUDY OF THE GIMEMA CML WORKING PARTY

EHA Library, Gabriele Gugliotta, 103206

ADDITIONAL PROGNOSTIC VALUE OF CIRCULATING MIR-16 EXPRESSION OVER THE USUAL PROGNOSTIC PARAMETERS IN MULTIPLE MYELOMA PATIENTS

EHA Library, Alberto Rocci, 103196

CENTRAL NERVOUS SYSTEM ACUTE LYMPHOBLASTIC LEUKEMIA IS MEDIATED BY VASCULAR ENDOTHELIAL GROWTH FACTOR PROVIDING A NOVEL TARGET FOR DIRECTED THERAPY

EHA Library, Vera Muench, 103116

USEFULNESS OF TARGETED NEXT-GENERATION SEQUENCING IN INHERITED PLATELET DISORDERS WITH UNSPECIFIC PHENOTYPE

EHA Library, Jose Maria Bastida Bermejo, 103080

SUBCUTANEOUS VERSUS INTRAVENOUS RITUXIMAB IN COMBINATION WITH CHOP FOR PREVIOUSLY UNTREATED DIFFUSE LARGE B-CELL LYMPHOMA: EFFICACY AND SAFETY RESULTS FROM THE PHASE IIIB MABEASE STUDY

EHA Library, Pieternella (Elly) Lugtenburg, 103114

ANALYSIS OF PROGNOSTIC MARKERS IN 615 PATIENTS WITH THERAPY-RELATED MYELODYSPLASTIC SYNDROMES - ARE CURRENTLY AVAILABLE SCORING SYSTEMS SUITABLE IN THIS PATIENT GROUP?

EHA Library, Andrea Kündgen, 103215

ANALYSIS OF TREATMENT AND OUTCOME DATA OF 2904 PATIENTS FROM THE EUTOS POPULATION-BASED REGISTRY

EHA Library, Verena Hoffmann, 103127

COMPOSITE INDEX FOR RISK PREDICTION IN RELAPSED CHILDHOOD ACUTE LYMPHOBLASTIC LEUKAEMIA

EHA Library, Anthony Moorman, 103109

CLINICAL OUTCOME IN OLDER AML PATIENTS NOT FIT FOR INTENSIVE CHEMOTHERAPY: RESULTS OF THE POPULATION-BASED AMLSG-BIO (NCT01252485) REGISTRY STUDY OF THE GERMAN-AUSTRIAN AML STUDY GROUP

EHA Library, Richard Schlenk, 103168

THE PRESENCE OF GENOMIC IMBALANCES IS ASSOCIATED WITH WORSE OUTCOME IN PATIENTS WITH BURKITT LYMPHOMA TREATED WITH DOSE-INTENSIVE CHEMOTHERAPY INCLUDING RITUXIMAB

EHA Library, Jesús MHernández-Rivas, 103082

AN INNOVATIVE HUMANIZED MOUSE MODEL TO INVESTIGATE THE INTERPLAY BETWEEN IMMUNE SYSTEM AND ACUTE MYELOID LEUKEMIA IN ALLOGENEIC HSCT

EHA Library, Giacomo Oliveira, 103214

BLEEDING RISK OF SURGERY IN PATIENTS WITH INHERITED PLATELET FUNCTION DISORDERS (IPFD): OUTCOME OF 389 SURGERIES IN 205 PATIENTS

EHA Library, PAOLO GRESELE, 103165

HEME AND IRON CONTROL OF MACROPHAGE PLASTICITY IS PREVENTED BY THE HEME SCAVENGER HEMOPEXIN AND THE IRON CHELATOR DFO: LESSON FROM SICKLE CELL ANEMIA.

EHA Library, Francesca Vinchi, 103133

CLINICAL AND MOLECULAR PREDICTORS OF RESPONSE TO ERYTHROPOIESIS STIMULATING AGENTS (ESA) IN LOWER RISK MDS PATIENTS

EHA Library, Sophie Park, 103058

EXPRESSION LEVELS OF CD38 AND COMPLEMENT INHIBITORY PROTEINS CD55 AND CD59 PREDICT RESPONSE TO DARATUMUMAB IN MULTIPLE MYELOMA

EHA Library, Lotte van der Wagen, 103222

TP-0184 LOWERS HEPCIDIN LEVELS AND IS A POTENTIAL THERAPEUTIC FOR ANEMIA OF CHRONIC DISEASE

EHA Library, Steven Warner, 103178

ABERRANT EXPRESSION OF THE STEM CELL MICRORNA-126 INDUCES B CELL MALIGNANCY

EHA Library, Silvia Nucera, 103086

EXOME SEQUENCING POINTS TO DIFFERENCES IN GENETIC INSTABILITY LEVEL IN MGUS COMPARED TO MM

EHA Library, Aneta Mikulasova, 103212

EFFICACY AND SAFETY OF FRONTLINE NILOTINIB IN 1089 EUROPEAN PATIENTS (PTS) WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE (CML-CP): ENEST1ST FINAL ANALYSIS

EHA Library, Andreas Hochhaus, 103063

CONTINUED IMPROVEMENT IN SURVIVAL OF ACUTE MYELOID LEUKEMIA PATIENTS AND AN APPLICATION OF THE LOSS IN EXPECTATION OF LIFE

EHA Library, Åsa Derolf, 103219

PROGRESSIVE ANEMIA CAN BE DETECTED MORE THAN 2 YEARS PRIOR TO THE DIAGNOSIS OF MYELODYSPLASTIC SYNDROME: RESULTS FROM THE PRIMARY CARE SETTING IN DENMARK

EHA Library, Jakob Werner Hansen, 103126

LEUKEMIA RELAPSES AFTER ALLOGENENIC HSCT DISPLAY A DISTINCTIVE IMMUNE-RELATED SIGNATURE, WITH FUNCTIONALLY RELEVANT ALTERATIONS IN HLA CLASS II ANTIGEN PRESENTATION AND T CELL COSTIMULATION

EHA Library, Cristina TOFFALORI, 103154

THE B CELL RECEPTOR SIGNALING OUTPUT IN BURKITT?S LYMPHOMA IS GENOTYPE-SPECIFIC AND IMPACTS SENSITIVITY TOWARDS BCR SIGNALING INHIBITORS

EHA Library, Thomas Oellerich, 103128

DOWN-REGULATED BETA2-GPI IS ASSOCIATED WITH A REDUCED ABILITY TO MITIGATE COMPLEMENT ACTIVATION BY INHIBITING JNK/BID-DEPENDENT PLATELET DESTRUCTION IN THE PATHOGENESIS OF IMMUNE THROMBOCYTOPAENIA

EHA Library, Xiaohui Zhang, 103105

Haematologica Celebration Session: Making blood: the niche in health and disease

EHA Library, David Scadden, 103641

CAR-T Cells

EHA Library, Carl June, 103664

Iron: a global issue in hematology

EHA Library, Clara Camaschella, 103663

Jean Bernard Lifetime Achievement Award: Acceptance Speech

EHA Library, Volker Diehl, 103671

PHASE 2 STUDY OF DARATUMUMAB MONOTHERAPY IN PATIENTS WITH ?3 LINES OF PRIOR THERAPY OR DOUBLE REFRACTORY MULTIPLE MYELOMA: 54767414MMY2002 (SIRIUS)

EHA Library, Sagar Lonial, 103136

CLINICAL ACTIVITY OF ERY001 (ERYTHROCYTE ENCAPSULATED L-ASPARAGINASE) IN COMBINATION WITH COOPRALL REGIMEN IN PHASE 3 RANDOMIZED TRIAL IN PATIENTS WITH RELAPSED ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Yves Bertrand, 103145

ADHERENCE AND DOSE INTENSITY FOLLOWING ADMINISTRATION OF THE IBRUTINIB 420 MG DOSE IN PATIENTS WITH PREVIOUSLY TREATED CLL

EHA Library, Ulrich Jäger, 103137

MICRORNA EXPRESSION BASED OUTCOME PREDICTION IN AML ? CROSS-PLATFORM INTEGRATIVE ANALYSES LEAD THE WAY TO NOVEL INSIGHTS

EHA Library, Velizar Shivarov, 103124

UCART19, AN ALLOGENEIC 'OFF-THE-SHELF' ADOPTIVE T-CELL IMMUNOTHERAPY AGAINST CD19+ B-CELL LEUKEMIAS

EHA Library, Julianne Smith, 103230

A HYPOPHOSPHORYLATED AUTOANTIGEN IS THE FIRST MOLECULARLY DEFINED RISK FACTOR AND A DOMINANT ANTIGENIC TARGET / STIMULUS OF THE B-CELL RECEPTOR FROM ABC-TYPE DLBCL

EHA Library, Michael Pfreundschuh, 103187

OUTCOMES OF ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION (HCT) IN PATIENTS WITH MYELOFIBROSIS (MF) EXPOSED TO JAK1/2 INHIBITORS

EHA Library, Mohamed Shanavas, 103073

RUNX1 MUTATION AND/OR DISRUPTION OF THE C-TERMINAL DOMAIN MAY BE CRITICAL FOR CHRONIC MYELOID LEUKAEMIA (CML) BLAST CRISIS TRANSFORMATION

EHA Library, Lihui Wang, 103066

UPDATED RESULTS OF A MULTICENTER PHASE I/IB STUDY OF CTLA4 BLOCKADE WITH IPILIMUMAB FOR RELAPSED HEMATOLOGIC MALIGNANCIES AFTER ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION

EHA Library, Matthew Davids, 103200

ALLOGENIC ADOPTIVE IMMUNOTHERAPY OF ACUTE MYELOID LEUKEMIA (AML) BY TARGETING CD123 WITH CAR T-CELLS

EHA Library, Roman Galetto, 103221

GENOMIC DNA BREAKPOINTS IN MLL AND TRANSLOCATION PARTNER GENES IN A LARGE COHORT OF INFANTS WITH ACUTE LEUKEMIA

EHA Library, Grigory Tsaur, 103220

MUTATION ANALYSIS OF EPIGENETIC MODIFIERS IN CHRONIC PHASE CML USING NEXT GENERATION SEQUENCING

EHA Library, Georgios Nteliopoulos, 103229

UTILIZING EXOSOMES AS INNOVATIVE MICRORNA BIOMARKERS AND TARGETED DRUG-DELIVERY VEHICLES IN ACUTE MYELOID LEUKEMIA

EHA Library, Rose McGlauflin, 103115

ALLOGENEIC TRANSPLANTATION FOR MYELOFIBROSIS: HIGH DOSE INTENSITY AND EARLY DISEASE STATE ARE FAVORABLE PROGNOSTIC FACTORS.

EHA Library, Uday Popat, 103097

TARGETING EPITHELIAL TO MESENCHYMAL TRANSITION (EMT) THROUGH CXCR4 BLOCKADE IN MULTIPLE MYELOMA

EHA Library, Aldo Roccaro, 103406

EXCELLENT LONG-TERM PROGNOSIS OF IMATINIB-TREATED FIP1L1-PDGFRA POSITIVE EOSINOPHILIA-ASSOCIATED MYELOPROLIFERATIVE NEOPLASM IN CHRONIC OR BLAST PHASE

EHA Library, Georgia Metzgeroth, 103077

EFFECT OF AGE ON EFFICACY AND SAFETY OUTCOMES IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA RECEIVING LENALIDOMIDE AND LOW-DOSE DEXAMETHASONE (RD): THE FIRST TRIAL

EHA Library, Cyrille Hulin, 103067

BCL6 AND EZH2 COOPERATE TO ASSEMBLE NON-CANONICAL PRC1-BCOR COMPLEX TO MEDIATE GERMINAL CENTER FORMATION AND PROMOTE LYMPHOMAGENESIS BY REPRESSING BIVALENT CHROMATIN DOMAINS

EHA Library, Wendy Beguelin, 103199

EARLY CLINICAL ACTIVITY AND PHARMACODYNAMIC EFFECTS OF DUVELISIB, A PI3K-DELTA,GAMMA INHIBITOR, IN PATIENTS WITH TREATMENT-NA

EHA Library, Susan O'Brien, 103207

A THERAPEUTIC NKT CELL ADJUVANT-BASED VACCINE INDUCES AN EFFECTIVE ANTITUMORAL IMMUNE RESPONSE IN B-CELL LYMPHOMA

EHA Library, Laura Escribà, 103143

CORRECTION OF MUTATIONS OF THE EPIGENETIC MODIFIER ASXL1 IN MYELOID LEUKEMIA CELLS BY CRISPR/CAS9 GENOME EDITING

EHA Library, Simona Valletta, 103146

IDENTIFICATION OF DIFFERENTIALLY METHYLATED DISTANT ENHANCERS RELATED TO ABERRANT EXPRESSION OF SOX11 IN MANTLE CELL LYMPHOMA

EHA Library, Renée Beekman, 103148

HIGH THROUGHPUT SEQUENCING AS A MEASURE OF EARLY RESPONSE TO THERAPY IN CHILDHOOD ALL

EHA Library, Ilan Kirsch, 103135

RUXOLITINIB (RUX) IN COMBINATION WITH 5-AZACYTIDINE (AZA) AS THERAPY FOR PATIENTS (PTS) WITH MYELOFIBROSIS (MF)

EHA Library, Naval Daver, 103158

THE QUADRUPLET COMBINATION OF CARFILZOMIB, CYCLOPHOSPHAMIDE, LENALIDOMIDE, AND DEXAMETHASONE IS SAFE AND WELL TOLERATED AS INDUCTION THERAPY FOR NEWLY DIAGNOSED, TRANSPLANT ELIGIBLE, MYELOMA PATIENTS.

EHA Library, Charlotte Pawlyn, 103110

HUMAN ATRIAL NATRIURETIC PEPTIDE (HANP) THERAPY IN THE EARLY PHASE AFTER ALLOGENEIC STEM CELL TRANSPLANT (ALLO-SCT) PREVENTS DEVELOPMENT OF CHRONIC KIDNEY DISEASE (CKD): RESULTS FROM A PHASE 2 STUDY

EHA Library, Hiroaki Shimizu, 103070

JAM-C: A NEW LEUKEMIC STEM CELL BIOMARKER IN ACUTE MYELOID LEUKEMIA

EHA Library, Maria De Grandis, 103065

TGR-1202, A NOVEL ONCE DAILY PI3K-DELTA INHIBITOR, DEMONSTRATES CLINICAL ACTIVITY WITH A FAVORABLE SAFETY PROFILE, LACKING HEPATOTOXICITY, IN PATIENTS WITH CLL AND B-CELL LYMPHOMA

EHA Library, Howard A.Burris, 103192

NPM-ALK MIMICS THYMIC PRE-T CELL RECEPTOR (TCR) EXPANSION BUT REQUIRES TRANSIENT TCR EXPRESSION FOR THYMIC EGRESS AND PERIPHERAL ANAPLASTIC LARGE CELL LYMPHOMA DEVELOPMENT

EHA Library, Amélie Trinquand, 103155

MYC-MAX HETERODYMER POSITIVELY REGULATES BCR AND BCR/ABL EXPRESSION

EHA Library, Vera Magistroni, 103142

EFFECT OF CARFILZOMIB, LENALIDOMIDE, AND DEXAMETHASONE VS LENALIDOMIDE AND DEXAMETHASONE IN PATIENTS WITH RELAPSED MULTIPLE MYELOMA BY LINE OF THERAPY: INTERIM RESULTS FROM THE PHASE 3 ASPIRE STUDY

EHA Library, Meletios Dimopoulos, 103134

GENERATION OF EBV-SPECIFIC AND EBV-SPECIFIC, TCR-REPROGRAMMED HUMAN CD8+ CYTOTOXIC T LYMPHOCYTES WITH STEM CELL MEMORY AND CENTRAL MEMORY PROPERTIES BY MODULATING GLYCOLYTIC T CELL METABOLISM

EHA Library, Udo Hartwig, 103117

RUXOLITINIB VERSUS BEST AVAILABLE THERAPY IN PATIENTS WITH POLYCYTHEMIA VERA: 80-WEEK FOLLOW-UP FROM THE RESPONSE TRIAL

EHA Library, Jean-Jacques Kiladjian, 103108

Mycosis Fungoides: Diagnostic Considerations

EHA Library, Patty Jansen, 103613

THE PREDICTIVE STRENGTH OF NEXT GENERATION SEQUENCING MINIMAL RESIDUAL DISEASE DETECTION FOR RELAPSE COMPARED WITH CURRENT METHODS IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Michaela Kotrová, 103071

LEUKAEMIA-ASSOCIATED SOMATIC MUTATIONS DRIVE DISTINCT PATTERNS OF AGE-RELATED CLONAL HAEMOPOIESIS

EHA Library, Thomas McKerrell, 103060

KIR2DS4 AND ITS VARIANT KIR1D ARE ASSOCIATED WITH AGVHD, CMV AND OS AFTER SIBING RELATED HLA MATCHED TRANSPLANTATION FOR PATIENTS WHOSE DONORS BELONG TO KIR GENE HAPLOTYPE A

EHA Library, Xiaojin Wu, 103052

DNMT3A MUTATIONS IN ACUTE MYELOID LEUKEMIA (AML): MONITORING OF MINIMAL RESIDUAL DISEASE (MRD). A STUDY OF THE AML STUDY GROUP (AMLSG).

EHA Library, Verena I Gaidzik, 103190

OUTCOMES OF GENE THERAPY FOR ?-THALASSEMIA MAJOR AND SEVERE SICKLE DISEASE VIA TRANSPLANTATION OF AUTOLOGOUS HEMATOPOIETIC STEM CELLS TRANSDUCED EX VIVO WITH A LENTIVIRAL BETA GLOBIN VECTOR

EHA Library, Marina Cavazzana-Calvo, 103175

RISK FACTORS FOR THROMBOHEMORRHAGIC AND TRANSFORMATION EVENTS IN 3649 HIGH-RISK PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA: RESULTS FROM THE PROSPECTIVE LONG-TERM OBSERVATIONAL EXELS STUDY

EHA Library, Gunnar Birgegard, 103157

DROPLET DIGITAL PCR FOR DNMT3A AND IDH1/2 MUTATIONS TO IMPROVE EARLY DETECTION OF ACUTE MYELOID LEUKEMIA RELAPSE AFTER ALLOGENEIC HSCT

EHA Library, Chiara Brambati, 103151

VENETOCLAX (ABT-199 / GDC-0199) COMBINED WITH RITUXIMAB INDUCES DEEP RESPONSES IN PATIENTS WITH RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Andrew W Roberts, 103125

SECOND GENERATION TYROSINE KINASE INHIBITORS SUPPRESS THE CIP2A/C-MYC/E2F1 PATHWAY

EHA Library, Richard Clark, 103121

TYROSINE KINASE FUSION GENES IN PEDIATRIC BCR-ABL1-LIKE ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Judith Boer, 103107

RESULTS FROM TWO PHASE 3 STUDIES OF POST-TRANSPLANT BORTEZOMIB (BTZ) CONSOLIDATION VS OBSERVATION (OBS) IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM)

EHA Library, Hermann Einsele, 103092

THE LANDSCAPE OF SOMATIC ALTERATIONS IN ADULT T-CELL LEUKEMIA/LYMPHOMA

EHA Library, Keisuke Kataoka, 103057

Novel Biological Insights In Primary Cutaneous T-cell Lymphomas Other Than Mycosis Fungoides

EHA Library, Leticia Quintanilla de Fend, 103612

Therapeutic principles in primary cutaneous T-cell lymphomas

EHA Library, Emmanuella Guenova, 103614

AMR - A threat to modern medicine

EHA Library, Sally Davies, 103674

RUNX1 and ETS abnormalities in T-ALL

EHA Library, Vahid Asnafi, 103660

Gene Therapy

EHA Library, Marina Cavazzana-Calvo, 103617

Chromothripsis in ALL - the chromosome 21 model

EHA Library, Christine Harrison, 103659

Novel erythropoiesis stimulating agents in thalassemia

EHA Library, John Porter, 103616

New treatments in SCD

EHA Library, Lucia de Franceschi, 103618

Genome wide molecular signatures in acute leukemia

EHA Library, Joost Martens, 103658

Signaling inhibitors: what is the next step?

EHA Library, John Byrd, 103578

The CLL epigenome: biological and clinical insights

EHA Library, Iñaki Martin-Subero, 103576

The genomic landscape of CLL: clinical implications

EHA Library, Gianluca Gaidano, 103577